Aaron L. Cox
Aaron L. Cox is Executive Vice President-Finance at Horizon Therapeutics Plc.
He received an MBA from The University of Chicago Booth School of Business and an undergraduate degree from the University of Notre Dame.
NAS: HZNP
After Hours
--Quotes are delayed by 20 min
May 27, 2022, 5:17 p.m.
$
94.84
Change
0.00 0.00%
Volume
Volume 164,431
Quotes are delayed by 20 min
Previous close
$ 90.59
$ 94.84
Change
+4.25 +4.69%
Day low
Day high
$90.48
$94.86
52 week low
52 week high
$82.51
$120.54
Aaron L. Cox is Executive Vice President-Finance at Horizon Therapeutics Plc.
He received an MBA from The University of Chicago Booth School of Business and an undergraduate degree from the University of Notre Dame.
Mr. Timothy P. Walbert Chairman, President & Chief Executive Officer |
Mr. Aaron L. Cox Chief Financial Officer & Executive Vice President |
Dr. Karin Rosen Chief Scientific Officer |
Dr. Elizabeth H. Z. Thompson Executive Vice President-Research & Development |
Dr. Jeffrey W. Sherman Chief Medical Officer & Executive Vice President |
Mr. Michael A. DesJardin Executive VP-Technical Operations & Quality |
Dr. Jeffrey D. Kent Executive VP-Medical Affairs & Outcomes Research |
Mr. Andy Pasternak Chief Strategy Officer & Executive Vice President |
Ms. Holly Copeland Senior Director-Corporate Social Responsibility |
Ms. Marilyn Vetter Group Vice President-Market Access |
Mr. Vikram Karnani President-International & Executive Vice President |
Mr. Miles W. McHugh Chief Accounting Officer & Senior Vice President |
Ms. Tina Ventura Chief Investor Relations Officer & Senior VP |
Ms. Jane Gonnerman Chief of Staff & Group Vice President-Development |
Ms. Irina P. Konstantinovsky EVP, Chief Human Resources & Diversity Officer |
Mr. David Caraher Secretary |
Mr. Sean M. Clayton Executive Vice President & General Counsel |
Dr. Susan Mahony Independent Director |
Mr. Michael G. Grey Lead Independent Director |
Dr. Jeff Himawan Independent Director |
Mr. William Francis Daniel Independent Director |
Ms. Pascale Witz Independent Director |
Dr. James Samuel Shannon Independent Director |
Mr. H. Thomas Watkins Independent Director |
Mr. Gino Santini Independent Director |
Withdrawing from your 401(k) or IRA in a down market? What you need to know
Elon Musk says SpaceX accepting dogecoin ‘soon’, joining Tesla
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
The share of adults who say they would be able to cover a $400 emergency expense reaches 9-year high
Airlines face severe pilot shortage as summer travel season nears
War surges Norway’s oil, gas profit. Now, it’s urged to help
The S&P 500 may be finding a short-term bottom — but the intermediate worries remain
‘Lots of stagflation in the new home market’: Homebuilder ETFs are struggling
Virtual Stock Exchange